Nafadotride preferential dopamine D3 receptor antagonist. References: Banasikowski TJ, MacLeod LS, Beninger RJ. Comparison of nafadotride, CNQX, and haloperidol on acquisition versus expression of amphetamine-conditioned place preference in rats. Behav Pharmacol. 2012 Feb;23(1):89-97. doi: 10.1097/FBP.0b013e32834ecb32. PubMed PMID: 22157177.

纯度：≥98%

CAS：390412-29-0